Global Blood Proteomics Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Blood Proteomics Services market size was valued at US$ 836 million in 2025 and is forecast to a readjusted size of US$ 1774 million by 2032 with a CAGR of 11.6% during review period.
Blood Proteomics Services refer to specialized research services that utilize advanced proteomics technologies to systematically identify, quantify, and interpret proteins from blood-derived biological samples, including plasma, serum, whole blood, and peripheral blood cells.
By analyzing circulating proteins, blood proteomics provides comprehensive insights into physiological conditions, disease progression, therapeutic responses, and biomarker discovery. Compared with genomics and transcriptomics, blood proteomics directly measures functional molecules that execute biological activities, making it highly valuable for understanding disease phenotypes and developing precision medicine solutions.
Blood Proteomics Services typically integrate high-resolution liquid chromatography tandem mass spectrometry (LC-MS/MS), data-independent acquisition (DIA), parallel reaction monitoring (PRM), multiplex immunoassays, proximity extension assays (PEA), and aptamer-based protein profiling technologies. These services cover the complete workflow from blood sample preparation, protein extraction, analytical detection, quantitative profiling, computational analysis, biomarker identification, and biological interpretation.
Currently, blood proteomics services are widely applied in biomarker discovery, clinical trial support, drug mechanism studies, population-scale health research, oncology, cardiovascular disease research, neurological disorders, autoimmune diseases, and precision medicine. With advances in artificial intelligence, large-scale biobanks, and multi-omics integration, blood proteomics has become a critical platform connecting biomedical research with clinical translation.
Blood Proteomics Services primarily operate under a technology-driven CRO model combining advanced analytical platforms, specialized laboratory expertise, and bioinformatics capabilities.
Service providers typically establish integrated infrastructure including mass spectrometry platforms, automated sample preparation systems, protein profiling technologies, and computational analysis pipelines. Typical workflows include study design, blood sample quality control, plasma/serum preparation, depletion of high-abundance proteins, enzymatic digestion, mass spectrometry or affinity-based detection, data processing, statistical analysis, biomarker discovery, and final reporting.
The upstream value chain includes mass spectrometry manufacturers, chromatography suppliers, antibody and reagent providers, aptamer technology companies, bioinformatics software suppliers, and laboratory consumable manufacturers. The midstream consists of proteomics CRO companies, clinical research service providers, and multi-omics analysis platforms. Downstream customers include pharmaceutical companies, biotechnology firms, academic institutions, hospitals, biobanks, and precision medicine organizations.
Blood Proteomics Services represent a high-value-added segment in life science research. Standardized plasma proteomics services generally achieve gross margins of approximately 40%-60%. Advanced services based on deep proteomics, DIA workflows, clinical cohorts, and drug discovery applications typically generate gross margins of 55%-75% due to higher equipment investment, analytical complexity, and data value. Companies with proprietary platforms, databases, computational capabilities, and pharmaceutical partnerships may achieve margins around 70%.
Blood Proteomics Services are becoming a strategic growth area in precision medicine and innovative drug development. As biomedical research moves from genomic information toward functional protein regulation, demand for circulating biomarkers, disease prediction, and treatment response analysis continues to increase.
By enabling large-scale profiling of circulating proteins, blood proteomics can identify disease-related molecular signals that are difficult to capture using traditional approaches. It provides new opportunities in cancer screening, immunotherapy, neurological research, and chronic disease management. The development of large-scale biobanks, artificial intelligence analytics, and multi-omics integration will further accelerate commercialization. Olink platforms have been adopted by pharmaceutical companies and research institutions worldwide to support proteomics research and translational applications.
The blood proteomics service market faces challenges including high analytical costs, extremely broad protein concentration ranges, difficulty detecting low-abundance proteins, and limited standardization among platforms.
High-abundance plasma proteins may interfere with the detection of disease-related low-abundance biomarkers, requiring advanced depletion strategies, deep mass spectrometry workflows, and highly sensitive detection technologies. In addition, complex proteomics datasets require advanced computational capabilities, creating significant entry barriers. Data standards, quality control, and regulatory requirements will become increasingly important as clinical applications expand.
Future demand for Blood Proteomics Services will increasingly focus on clinical translation, population-scale studies, and pharmaceutical applications.
Pharmaceutical companies will utilize blood proteomics for target discovery, mechanism-of-action studies, patient stratification, and companion diagnostic development. Biotechnology companies will increasingly rely on CRO providers to reduce infrastructure investment and accelerate innovation programs. Research institutions and hospitals will expand applications in oncology, cardiovascular disease, neurological disorders, and immune-related diseases.
With the continued growth of precision medicine and AI-driven life sciences, Blood Proteomics Services providers with high-throughput capabilities, advanced analytics, proprietary databases, and global delivery networks will gain stronger competitive positions in the future market.
Report Scope
This report is a detailed and comprehensive analysis for global Blood Proteomics Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Blood Proteomics Services market size and forecasts, in consumption value ($ Million), 2021-2032
Global Blood Proteomics Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Blood Proteomics Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Blood Proteomics Services market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Blood Proteomics Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Blood Proteomics Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Blood Proteomics Services, with revenue, gross margin, and global market share of Blood Proteomics Services from 2021 to 2026.
Chapter 3, the Blood Proteomics Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Blood Proteomics Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Blood Proteomics Services.
Chapter 13, to describe Blood Proteomics Services research findings and conclusion.
Blood Proteomics Services refer to specialized research services that utilize advanced proteomics technologies to systematically identify, quantify, and interpret proteins from blood-derived biological samples, including plasma, serum, whole blood, and peripheral blood cells.
By analyzing circulating proteins, blood proteomics provides comprehensive insights into physiological conditions, disease progression, therapeutic responses, and biomarker discovery. Compared with genomics and transcriptomics, blood proteomics directly measures functional molecules that execute biological activities, making it highly valuable for understanding disease phenotypes and developing precision medicine solutions.
Blood Proteomics Services typically integrate high-resolution liquid chromatography tandem mass spectrometry (LC-MS/MS), data-independent acquisition (DIA), parallel reaction monitoring (PRM), multiplex immunoassays, proximity extension assays (PEA), and aptamer-based protein profiling technologies. These services cover the complete workflow from blood sample preparation, protein extraction, analytical detection, quantitative profiling, computational analysis, biomarker identification, and biological interpretation.
Currently, blood proteomics services are widely applied in biomarker discovery, clinical trial support, drug mechanism studies, population-scale health research, oncology, cardiovascular disease research, neurological disorders, autoimmune diseases, and precision medicine. With advances in artificial intelligence, large-scale biobanks, and multi-omics integration, blood proteomics has become a critical platform connecting biomedical research with clinical translation.
Blood Proteomics Services primarily operate under a technology-driven CRO model combining advanced analytical platforms, specialized laboratory expertise, and bioinformatics capabilities.
Service providers typically establish integrated infrastructure including mass spectrometry platforms, automated sample preparation systems, protein profiling technologies, and computational analysis pipelines. Typical workflows include study design, blood sample quality control, plasma/serum preparation, depletion of high-abundance proteins, enzymatic digestion, mass spectrometry or affinity-based detection, data processing, statistical analysis, biomarker discovery, and final reporting.
The upstream value chain includes mass spectrometry manufacturers, chromatography suppliers, antibody and reagent providers, aptamer technology companies, bioinformatics software suppliers, and laboratory consumable manufacturers. The midstream consists of proteomics CRO companies, clinical research service providers, and multi-omics analysis platforms. Downstream customers include pharmaceutical companies, biotechnology firms, academic institutions, hospitals, biobanks, and precision medicine organizations.
Blood Proteomics Services represent a high-value-added segment in life science research. Standardized plasma proteomics services generally achieve gross margins of approximately 40%-60%. Advanced services based on deep proteomics, DIA workflows, clinical cohorts, and drug discovery applications typically generate gross margins of 55%-75% due to higher equipment investment, analytical complexity, and data value. Companies with proprietary platforms, databases, computational capabilities, and pharmaceutical partnerships may achieve margins around 70%.
Blood Proteomics Services are becoming a strategic growth area in precision medicine and innovative drug development. As biomedical research moves from genomic information toward functional protein regulation, demand for circulating biomarkers, disease prediction, and treatment response analysis continues to increase.
By enabling large-scale profiling of circulating proteins, blood proteomics can identify disease-related molecular signals that are difficult to capture using traditional approaches. It provides new opportunities in cancer screening, immunotherapy, neurological research, and chronic disease management. The development of large-scale biobanks, artificial intelligence analytics, and multi-omics integration will further accelerate commercialization. Olink platforms have been adopted by pharmaceutical companies and research institutions worldwide to support proteomics research and translational applications.
The blood proteomics service market faces challenges including high analytical costs, extremely broad protein concentration ranges, difficulty detecting low-abundance proteins, and limited standardization among platforms.
High-abundance plasma proteins may interfere with the detection of disease-related low-abundance biomarkers, requiring advanced depletion strategies, deep mass spectrometry workflows, and highly sensitive detection technologies. In addition, complex proteomics datasets require advanced computational capabilities, creating significant entry barriers. Data standards, quality control, and regulatory requirements will become increasingly important as clinical applications expand.
Future demand for Blood Proteomics Services will increasingly focus on clinical translation, population-scale studies, and pharmaceutical applications.
Pharmaceutical companies will utilize blood proteomics for target discovery, mechanism-of-action studies, patient stratification, and companion diagnostic development. Biotechnology companies will increasingly rely on CRO providers to reduce infrastructure investment and accelerate innovation programs. Research institutions and hospitals will expand applications in oncology, cardiovascular disease, neurological disorders, and immune-related diseases.
With the continued growth of precision medicine and AI-driven life sciences, Blood Proteomics Services providers with high-throughput capabilities, advanced analytics, proprietary databases, and global delivery networks will gain stronger competitive positions in the future market.
Report Scope
This report is a detailed and comprehensive analysis for global Blood Proteomics Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Blood Proteomics Services market size and forecasts, in consumption value ($ Million), 2021-2032
Global Blood Proteomics Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Blood Proteomics Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Blood Proteomics Services market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Blood Proteomics Services
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Blood Proteomics Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Blood Proteomics
- Blood Modification Proteomics
- Olink (Targeted) Proteomics
- Universities and Research Institutes
- Hospitals
- Pharmaceutical Companies
- Others
- Oncology
- Cardiovascular
- Agriculture
- Neuroscience
- Other
- Disease Biomarker Research
- Drug Development
- Clinical Research
- Others
- Olink (Thermo Fisher Scientific)
- SomaLogic (Illumina)
- Labcorp
- BostonGene
- CellCarta
- GENEWIZ (Azenta Life Sciences)
- CDI Labs
- Biognosys
- Discovery Life Sciences
- Firalis Molecular Precision
- Cell Signaling Technology (CST)
- Sampled (Infinity Biologix)
- APTBIO
- Sinotech Genomics
- Biodesix
- Panome Bio
- Novogene
- PTM BIO
- BGI Genomics
- Evotec
- Metware Biotechnology
- MRM Proteomics
- Lc-Bio Technologies
- Eurofins Scientific
- MtoZ-Biolabs
- Creative Proteomics
- Macrogen
- TATAA Biocenter
- OmicScouts (Momentum Biotechnologies)
- Precision Biomarker Laboratories (PBL)
- Shanghai OE Biotech
- RxCelerate
- Proteomics International
- Proteome Sciences
- Westlake Omics
- Crown Bioscience
- VProteomics
- Shanghai Majorbio Bio-Pharm
- Applied Biomics
- Sapient Bioanalytics
- Allumiqs
- MS Bioworks
- Shanghai Bioprofile
- Cosmos Wisdom
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Blood Proteomics Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Blood Proteomics Services, with revenue, gross margin, and global market share of Blood Proteomics Services from 2021 to 2026.
Chapter 3, the Blood Proteomics Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Blood Proteomics Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Blood Proteomics Services.
Chapter 13, to describe Blood Proteomics Services research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Blood Proteomics Services by Type
1.3.1 Overview: Global Blood Proteomics Services Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Blood Proteomics Services Consumption Value Market Share by Type in 2025
1.3.3 Blood Proteomics
1.3.4 Blood Modification Proteomics
1.3.5 Olink (Targeted) Proteomics
1.4 Classification of Blood Proteomics Services by End User
1.4.1 Overview: Global Blood Proteomics Services Market Size by End User: 2021 Versus 2025 Versus 2032
1.4.2 Global Blood Proteomics Services Consumption Value Market Share by End User in 2025
1.4.3 Universities and Research Institutes
1.4.4 Hospitals
1.4.5 Pharmaceutical Companies
1.4.6 Others
1.5 Classification of Blood Proteomics Services by Research Areas
1.5.1 Overview: Global Blood Proteomics Services Market Size by Research Areas: 2021 Versus 2025 Versus 2032
1.5.2 Global Blood Proteomics Services Consumption Value Market Share by Research Areas in 2025
1.5.3 Oncology
1.5.4 Cardiovascular
1.5.5 Agriculture
1.5.6 Neuroscience
1.5.7 Other
1.6 Global Blood Proteomics Services Market by Application
1.6.1 Overview: Global Blood Proteomics Services Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Disease Biomarker Research
1.6.3 Drug Development
1.6.4 Clinical Research
1.6.5 Others
1.7 Global Blood Proteomics Services Market Size & Forecast
1.8 Global Blood Proteomics Services Market Size and Forecast by Region
1.8.1 Global Blood Proteomics Services Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Blood Proteomics Services Market Size by Region, (2021-2032)
1.8.3 North America Blood Proteomics Services Market Size and Prospect (2021-2032)
1.8.4 Europe Blood Proteomics Services Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Blood Proteomics Services Market Size and Prospect (2021-2032)
1.8.6 South America Blood Proteomics Services Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Blood Proteomics Services Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Olink (Thermo Fisher Scientific)
2.1.1 Olink (Thermo Fisher Scientific) Details
2.1.2 Olink (Thermo Fisher Scientific) Major Business
2.1.3 Olink (Thermo Fisher Scientific) Blood Proteomics Services Product and Solutions
2.1.4 Olink (Thermo Fisher Scientific) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Olink (Thermo Fisher Scientific) Recent Developments and Future Plans
2.2 SomaLogic (Illumina)
2.2.1 SomaLogic (Illumina) Details
2.2.2 SomaLogic (Illumina) Major Business
2.2.3 SomaLogic (Illumina) Blood Proteomics Services Product and Solutions
2.2.4 SomaLogic (Illumina) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 SomaLogic (Illumina) Recent Developments and Future Plans
2.3 Labcorp
2.3.1 Labcorp Details
2.3.2 Labcorp Major Business
2.3.3 Labcorp Blood Proteomics Services Product and Solutions
2.3.4 Labcorp Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Labcorp Recent Developments and Future Plans
2.4 BostonGene
2.4.1 BostonGene Details
2.4.2 BostonGene Major Business
2.4.3 BostonGene Blood Proteomics Services Product and Solutions
2.4.4 BostonGene Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 BostonGene Recent Developments and Future Plans
2.5 CellCarta
2.5.1 CellCarta Details
2.5.2 CellCarta Major Business
2.5.3 CellCarta Blood Proteomics Services Product and Solutions
2.5.4 CellCarta Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 CellCarta Recent Developments and Future Plans
2.6 GENEWIZ (Azenta Life Sciences)
2.6.1 GENEWIZ (Azenta Life Sciences) Details
2.6.2 GENEWIZ (Azenta Life Sciences) Major Business
2.6.3 GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Product and Solutions
2.6.4 GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 GENEWIZ (Azenta Life Sciences) Recent Developments and Future Plans
2.7 CDI Labs
2.7.1 CDI Labs Details
2.7.2 CDI Labs Major Business
2.7.3 CDI Labs Blood Proteomics Services Product and Solutions
2.7.4 CDI Labs Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 CDI Labs Recent Developments and Future Plans
2.8 Biognosys
2.8.1 Biognosys Details
2.8.2 Biognosys Major Business
2.8.3 Biognosys Blood Proteomics Services Product and Solutions
2.8.4 Biognosys Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Biognosys Recent Developments and Future Plans
2.9 Discovery Life Sciences
2.9.1 Discovery Life Sciences Details
2.9.2 Discovery Life Sciences Major Business
2.9.3 Discovery Life Sciences Blood Proteomics Services Product and Solutions
2.9.4 Discovery Life Sciences Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Discovery Life Sciences Recent Developments and Future Plans
2.10 Firalis Molecular Precision
2.10.1 Firalis Molecular Precision Details
2.10.2 Firalis Molecular Precision Major Business
2.10.3 Firalis Molecular Precision Blood Proteomics Services Product and Solutions
2.10.4 Firalis Molecular Precision Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Firalis Molecular Precision Recent Developments and Future Plans
2.11 Cell Signaling Technology (CST)
2.11.1 Cell Signaling Technology (CST) Details
2.11.2 Cell Signaling Technology (CST) Major Business
2.11.3 Cell Signaling Technology (CST) Blood Proteomics Services Product and Solutions
2.11.4 Cell Signaling Technology (CST) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Cell Signaling Technology (CST) Recent Developments and Future Plans
2.12 Sampled (Infinity Biologix)
2.12.1 Sampled (Infinity Biologix) Details
2.12.2 Sampled (Infinity Biologix) Major Business
2.12.3 Sampled (Infinity Biologix) Blood Proteomics Services Product and Solutions
2.12.4 Sampled (Infinity Biologix) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Sampled (Infinity Biologix) Recent Developments and Future Plans
2.13 APTBIO
2.13.1 APTBIO Details
2.13.2 APTBIO Major Business
2.13.3 APTBIO Blood Proteomics Services Product and Solutions
2.13.4 APTBIO Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 APTBIO Recent Developments and Future Plans
2.14 Sinotech Genomics
2.14.1 Sinotech Genomics Details
2.14.2 Sinotech Genomics Major Business
2.14.3 Sinotech Genomics Blood Proteomics Services Product and Solutions
2.14.4 Sinotech Genomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Sinotech Genomics Recent Developments and Future Plans
2.15 Biodesix
2.15.1 Biodesix Details
2.15.2 Biodesix Major Business
2.15.3 Biodesix Blood Proteomics Services Product and Solutions
2.15.4 Biodesix Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Biodesix Recent Developments and Future Plans
2.16 Panome Bio
2.16.1 Panome Bio Details
2.16.2 Panome Bio Major Business
2.16.3 Panome Bio Blood Proteomics Services Product and Solutions
2.16.4 Panome Bio Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Panome Bio Recent Developments and Future Plans
2.17 Novogene
2.17.1 Novogene Details
2.17.2 Novogene Major Business
2.17.3 Novogene Blood Proteomics Services Product and Solutions
2.17.4 Novogene Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Novogene Recent Developments and Future Plans
2.18 PTM BIO
2.18.1 PTM BIO Details
2.18.2 PTM BIO Major Business
2.18.3 PTM BIO Blood Proteomics Services Product and Solutions
2.18.4 PTM BIO Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 PTM BIO Recent Developments and Future Plans
2.19 BGI Genomics
2.19.1 BGI Genomics Details
2.19.2 BGI Genomics Major Business
2.19.3 BGI Genomics Blood Proteomics Services Product and Solutions
2.19.4 BGI Genomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 BGI Genomics Recent Developments and Future Plans
2.20 Evotec
2.20.1 Evotec Details
2.20.2 Evotec Major Business
2.20.3 Evotec Blood Proteomics Services Product and Solutions
2.20.4 Evotec Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Evotec Recent Developments and Future Plans
2.21 Metware Biotechnology
2.21.1 Metware Biotechnology Details
2.21.2 Metware Biotechnology Major Business
2.21.3 Metware Biotechnology Blood Proteomics Services Product and Solutions
2.21.4 Metware Biotechnology Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Metware Biotechnology Recent Developments and Future Plans
2.22 MRM Proteomics
2.22.1 MRM Proteomics Details
2.22.2 MRM Proteomics Major Business
2.22.3 MRM Proteomics Blood Proteomics Services Product and Solutions
2.22.4 MRM Proteomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 MRM Proteomics Recent Developments and Future Plans
2.23 Lc-Bio Technologies
2.23.1 Lc-Bio Technologies Details
2.23.2 Lc-Bio Technologies Major Business
2.23.3 Lc-Bio Technologies Blood Proteomics Services Product and Solutions
2.23.4 Lc-Bio Technologies Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 Lc-Bio Technologies Recent Developments and Future Plans
2.24 Eurofins Scientific
2.24.1 Eurofins Scientific Details
2.24.2 Eurofins Scientific Major Business
2.24.3 Eurofins Scientific Blood Proteomics Services Product and Solutions
2.24.4 Eurofins Scientific Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 Eurofins Scientific Recent Developments and Future Plans
2.25 MtoZ-Biolabs
2.25.1 MtoZ-Biolabs Details
2.25.2 MtoZ-Biolabs Major Business
2.25.3 MtoZ-Biolabs Blood Proteomics Services Product and Solutions
2.25.4 MtoZ-Biolabs Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.25.5 MtoZ-Biolabs Recent Developments and Future Plans
2.26 Creative Proteomics
2.26.1 Creative Proteomics Details
2.26.2 Creative Proteomics Major Business
2.26.3 Creative Proteomics Blood Proteomics Services Product and Solutions
2.26.4 Creative Proteomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.26.5 Creative Proteomics Recent Developments and Future Plans
2.27 Macrogen
2.27.1 Macrogen Details
2.27.2 Macrogen Major Business
2.27.3 Macrogen Blood Proteomics Services Product and Solutions
2.27.4 Macrogen Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.27.5 Macrogen Recent Developments and Future Plans
2.28 TATAA Biocenter
2.28.1 TATAA Biocenter Details
2.28.2 TATAA Biocenter Major Business
2.28.3 TATAA Biocenter Blood Proteomics Services Product and Solutions
2.28.4 TATAA Biocenter Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.28.5 TATAA Biocenter Recent Developments and Future Plans
2.29 OmicScouts (Momentum Biotechnologies)
2.29.1 OmicScouts (Momentum Biotechnologies) Details
2.29.2 OmicScouts (Momentum Biotechnologies) Major Business
2.29.3 OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Product and Solutions
2.29.4 OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.29.5 OmicScouts (Momentum Biotechnologies) Recent Developments and Future Plans
2.30 Precision Biomarker Laboratories (PBL)
2.30.1 Precision Biomarker Laboratories (PBL) Details
2.30.2 Precision Biomarker Laboratories (PBL) Major Business
2.30.3 Precision Biomarker Laboratories (PBL) Blood Proteomics Services Product and Solutions
2.30.4 Precision Biomarker Laboratories (PBL) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.30.5 Precision Biomarker Laboratories (PBL) Recent Developments and Future Plans
2.31 Shanghai OE Biotech
2.31.1 Shanghai OE Biotech Details
2.31.2 Shanghai OE Biotech Major Business
2.31.3 Shanghai OE Biotech Blood Proteomics Services Product and Solutions
2.31.4 Shanghai OE Biotech Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.31.5 Shanghai OE Biotech Recent Developments and Future Plans
2.32 RxCelerate
2.32.1 RxCelerate Details
2.32.2 RxCelerate Major Business
2.32.3 RxCelerate Blood Proteomics Services Product and Solutions
2.32.4 RxCelerate Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.32.5 RxCelerate Recent Developments and Future Plans
2.33 Proteomics International
2.33.1 Proteomics International Details
2.33.2 Proteomics International Major Business
2.33.3 Proteomics International Blood Proteomics Services Product and Solutions
2.33.4 Proteomics International Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.33.5 Proteomics International Recent Developments and Future Plans
2.34 Proteome Sciences
2.34.1 Proteome Sciences Details
2.34.2 Proteome Sciences Major Business
2.34.3 Proteome Sciences Blood Proteomics Services Product and Solutions
2.34.4 Proteome Sciences Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.34.5 Proteome Sciences Recent Developments and Future Plans
2.35 Westlake Omics
2.35.1 Westlake Omics Details
2.35.2 Westlake Omics Major Business
2.35.3 Westlake Omics Blood Proteomics Services Product and Solutions
2.35.4 Westlake Omics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.35.5 Westlake Omics Recent Developments and Future Plans
2.36 Crown Bioscience
2.36.1 Crown Bioscience Details
2.36.2 Crown Bioscience Major Business
2.36.3 Crown Bioscience Blood Proteomics Services Product and Solutions
2.36.4 Crown Bioscience Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.36.5 Crown Bioscience Recent Developments and Future Plans
2.37 VProteomics
2.37.1 VProteomics Details
2.37.2 VProteomics Major Business
2.37.3 VProteomics Blood Proteomics Services Product and Solutions
2.37.4 VProteomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.37.5 VProteomics Recent Developments and Future Plans
2.38 Shanghai Majorbio Bio-Pharm
2.38.1 Shanghai Majorbio Bio-Pharm Details
2.38.2 Shanghai Majorbio Bio-Pharm Major Business
2.38.3 Shanghai Majorbio Bio-Pharm Blood Proteomics Services Product and Solutions
2.38.4 Shanghai Majorbio Bio-Pharm Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.38.5 Shanghai Majorbio Bio-Pharm Recent Developments and Future Plans
2.39 Applied Biomics
2.39.1 Applied Biomics Details
2.39.2 Applied Biomics Major Business
2.39.3 Applied Biomics Blood Proteomics Services Product and Solutions
2.39.4 Applied Biomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.39.5 Applied Biomics Recent Developments and Future Plans
2.40 Sapient Bioanalytics
2.40.1 Sapient Bioanalytics Details
2.40.2 Sapient Bioanalytics Major Business
2.40.3 Sapient Bioanalytics Blood Proteomics Services Product and Solutions
2.40.4 Sapient Bioanalytics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.40.5 Sapient Bioanalytics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Blood Proteomics Services Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Blood Proteomics Services by Company Revenue
3.2.2 Top 3 Blood Proteomics Services Players Market Share in 2025
3.2.3 Top 6 Blood Proteomics Services Players Market Share in 2025
3.3 Blood Proteomics Services Market: Overall Company Footprint Analysis
3.3.1 Blood Proteomics Services Market: Region Footprint
3.3.2 Blood Proteomics Services Market: Company Product Type Footprint
3.3.3 Blood Proteomics Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Blood Proteomics Services Consumption Value and Market Share by Type (2021-2026)
4.2 Global Blood Proteomics Services Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Blood Proteomics Services Consumption Value Market Share by Application (2021-2026)
5.2 Global Blood Proteomics Services Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Blood Proteomics Services Consumption Value by Type (2021-2032)
6.2 North America Blood Proteomics Services Market Size by Application (2021-2032)
6.3 North America Blood Proteomics Services Market Size by Country
6.3.1 North America Blood Proteomics Services Consumption Value by Country (2021-2032)
6.3.2 United States Blood Proteomics Services Market Size and Forecast (2021-2032)
6.3.3 Canada Blood Proteomics Services Market Size and Forecast (2021-2032)
6.3.4 Mexico Blood Proteomics Services Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Blood Proteomics Services Consumption Value by Type (2021-2032)
7.2 Europe Blood Proteomics Services Consumption Value by Application (2021-2032)
7.3 Europe Blood Proteomics Services Market Size by Country
7.3.1 Europe Blood Proteomics Services Consumption Value by Country (2021-2032)
7.3.2 Germany Blood Proteomics Services Market Size and Forecast (2021-2032)
7.3.3 France Blood Proteomics Services Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Blood Proteomics Services Market Size and Forecast (2021-2032)
7.3.5 Russia Blood Proteomics Services Market Size and Forecast (2021-2032)
7.3.6 Italy Blood Proteomics Services Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Blood Proteomics Services Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Blood Proteomics Services Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Blood Proteomics Services Market Size by Region
8.3.1 Asia-Pacific Blood Proteomics Services Consumption Value by Region (2021-2032)
8.3.2 China Blood Proteomics Services Market Size and Forecast (2021-2032)
8.3.3 Japan Blood Proteomics Services Market Size and Forecast (2021-2032)
8.3.4 South Korea Blood Proteomics Services Market Size and Forecast (2021-2032)
8.3.5 India Blood Proteomics Services Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Blood Proteomics Services Market Size and Forecast (2021-2032)
8.3.7 Australia Blood Proteomics Services Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Blood Proteomics Services Consumption Value by Type (2021-2032)
9.2 South America Blood Proteomics Services Consumption Value by Application (2021-2032)
9.3 South America Blood Proteomics Services Market Size by Country
9.3.1 South America Blood Proteomics Services Consumption Value by Country (2021-2032)
9.3.2 Brazil Blood Proteomics Services Market Size and Forecast (2021-2032)
9.3.3 Argentina Blood Proteomics Services Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Blood Proteomics Services Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Blood Proteomics Services Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Blood Proteomics Services Market Size by Country
10.3.1 Middle East & Africa Blood Proteomics Services Consumption Value by Country (2021-2032)
10.3.2 Turkey Blood Proteomics Services Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Blood Proteomics Services Market Size and Forecast (2021-2032)
10.3.4 UAE Blood Proteomics Services Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Blood Proteomics Services Market Drivers
11.2 Blood Proteomics Services Market Restraints
11.3 Blood Proteomics Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Blood Proteomics Services Industry Chain
12.2 Blood Proteomics Services Upstream Analysis
12.3 Blood Proteomics Services Midstream Analysis
12.4 Blood Proteomics Services Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Blood Proteomics Services by Type
1.3.1 Overview: Global Blood Proteomics Services Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Blood Proteomics Services Consumption Value Market Share by Type in 2025
1.3.3 Blood Proteomics
1.3.4 Blood Modification Proteomics
1.3.5 Olink (Targeted) Proteomics
1.4 Classification of Blood Proteomics Services by End User
1.4.1 Overview: Global Blood Proteomics Services Market Size by End User: 2021 Versus 2025 Versus 2032
1.4.2 Global Blood Proteomics Services Consumption Value Market Share by End User in 2025
1.4.3 Universities and Research Institutes
1.4.4 Hospitals
1.4.5 Pharmaceutical Companies
1.4.6 Others
1.5 Classification of Blood Proteomics Services by Research Areas
1.5.1 Overview: Global Blood Proteomics Services Market Size by Research Areas: 2021 Versus 2025 Versus 2032
1.5.2 Global Blood Proteomics Services Consumption Value Market Share by Research Areas in 2025
1.5.3 Oncology
1.5.4 Cardiovascular
1.5.5 Agriculture
1.5.6 Neuroscience
1.5.7 Other
1.6 Global Blood Proteomics Services Market by Application
1.6.1 Overview: Global Blood Proteomics Services Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Disease Biomarker Research
1.6.3 Drug Development
1.6.4 Clinical Research
1.6.5 Others
1.7 Global Blood Proteomics Services Market Size & Forecast
1.8 Global Blood Proteomics Services Market Size and Forecast by Region
1.8.1 Global Blood Proteomics Services Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Blood Proteomics Services Market Size by Region, (2021-2032)
1.8.3 North America Blood Proteomics Services Market Size and Prospect (2021-2032)
1.8.4 Europe Blood Proteomics Services Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Blood Proteomics Services Market Size and Prospect (2021-2032)
1.8.6 South America Blood Proteomics Services Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Blood Proteomics Services Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Olink (Thermo Fisher Scientific)
2.1.1 Olink (Thermo Fisher Scientific) Details
2.1.2 Olink (Thermo Fisher Scientific) Major Business
2.1.3 Olink (Thermo Fisher Scientific) Blood Proteomics Services Product and Solutions
2.1.4 Olink (Thermo Fisher Scientific) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Olink (Thermo Fisher Scientific) Recent Developments and Future Plans
2.2 SomaLogic (Illumina)
2.2.1 SomaLogic (Illumina) Details
2.2.2 SomaLogic (Illumina) Major Business
2.2.3 SomaLogic (Illumina) Blood Proteomics Services Product and Solutions
2.2.4 SomaLogic (Illumina) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 SomaLogic (Illumina) Recent Developments and Future Plans
2.3 Labcorp
2.3.1 Labcorp Details
2.3.2 Labcorp Major Business
2.3.3 Labcorp Blood Proteomics Services Product and Solutions
2.3.4 Labcorp Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Labcorp Recent Developments and Future Plans
2.4 BostonGene
2.4.1 BostonGene Details
2.4.2 BostonGene Major Business
2.4.3 BostonGene Blood Proteomics Services Product and Solutions
2.4.4 BostonGene Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 BostonGene Recent Developments and Future Plans
2.5 CellCarta
2.5.1 CellCarta Details
2.5.2 CellCarta Major Business
2.5.3 CellCarta Blood Proteomics Services Product and Solutions
2.5.4 CellCarta Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 CellCarta Recent Developments and Future Plans
2.6 GENEWIZ (Azenta Life Sciences)
2.6.1 GENEWIZ (Azenta Life Sciences) Details
2.6.2 GENEWIZ (Azenta Life Sciences) Major Business
2.6.3 GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Product and Solutions
2.6.4 GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 GENEWIZ (Azenta Life Sciences) Recent Developments and Future Plans
2.7 CDI Labs
2.7.1 CDI Labs Details
2.7.2 CDI Labs Major Business
2.7.3 CDI Labs Blood Proteomics Services Product and Solutions
2.7.4 CDI Labs Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 CDI Labs Recent Developments and Future Plans
2.8 Biognosys
2.8.1 Biognosys Details
2.8.2 Biognosys Major Business
2.8.3 Biognosys Blood Proteomics Services Product and Solutions
2.8.4 Biognosys Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Biognosys Recent Developments and Future Plans
2.9 Discovery Life Sciences
2.9.1 Discovery Life Sciences Details
2.9.2 Discovery Life Sciences Major Business
2.9.3 Discovery Life Sciences Blood Proteomics Services Product and Solutions
2.9.4 Discovery Life Sciences Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Discovery Life Sciences Recent Developments and Future Plans
2.10 Firalis Molecular Precision
2.10.1 Firalis Molecular Precision Details
2.10.2 Firalis Molecular Precision Major Business
2.10.3 Firalis Molecular Precision Blood Proteomics Services Product and Solutions
2.10.4 Firalis Molecular Precision Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Firalis Molecular Precision Recent Developments and Future Plans
2.11 Cell Signaling Technology (CST)
2.11.1 Cell Signaling Technology (CST) Details
2.11.2 Cell Signaling Technology (CST) Major Business
2.11.3 Cell Signaling Technology (CST) Blood Proteomics Services Product and Solutions
2.11.4 Cell Signaling Technology (CST) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Cell Signaling Technology (CST) Recent Developments and Future Plans
2.12 Sampled (Infinity Biologix)
2.12.1 Sampled (Infinity Biologix) Details
2.12.2 Sampled (Infinity Biologix) Major Business
2.12.3 Sampled (Infinity Biologix) Blood Proteomics Services Product and Solutions
2.12.4 Sampled (Infinity Biologix) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Sampled (Infinity Biologix) Recent Developments and Future Plans
2.13 APTBIO
2.13.1 APTBIO Details
2.13.2 APTBIO Major Business
2.13.3 APTBIO Blood Proteomics Services Product and Solutions
2.13.4 APTBIO Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 APTBIO Recent Developments and Future Plans
2.14 Sinotech Genomics
2.14.1 Sinotech Genomics Details
2.14.2 Sinotech Genomics Major Business
2.14.3 Sinotech Genomics Blood Proteomics Services Product and Solutions
2.14.4 Sinotech Genomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Sinotech Genomics Recent Developments and Future Plans
2.15 Biodesix
2.15.1 Biodesix Details
2.15.2 Biodesix Major Business
2.15.3 Biodesix Blood Proteomics Services Product and Solutions
2.15.4 Biodesix Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Biodesix Recent Developments and Future Plans
2.16 Panome Bio
2.16.1 Panome Bio Details
2.16.2 Panome Bio Major Business
2.16.3 Panome Bio Blood Proteomics Services Product and Solutions
2.16.4 Panome Bio Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Panome Bio Recent Developments and Future Plans
2.17 Novogene
2.17.1 Novogene Details
2.17.2 Novogene Major Business
2.17.3 Novogene Blood Proteomics Services Product and Solutions
2.17.4 Novogene Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Novogene Recent Developments and Future Plans
2.18 PTM BIO
2.18.1 PTM BIO Details
2.18.2 PTM BIO Major Business
2.18.3 PTM BIO Blood Proteomics Services Product and Solutions
2.18.4 PTM BIO Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 PTM BIO Recent Developments and Future Plans
2.19 BGI Genomics
2.19.1 BGI Genomics Details
2.19.2 BGI Genomics Major Business
2.19.3 BGI Genomics Blood Proteomics Services Product and Solutions
2.19.4 BGI Genomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 BGI Genomics Recent Developments and Future Plans
2.20 Evotec
2.20.1 Evotec Details
2.20.2 Evotec Major Business
2.20.3 Evotec Blood Proteomics Services Product and Solutions
2.20.4 Evotec Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Evotec Recent Developments and Future Plans
2.21 Metware Biotechnology
2.21.1 Metware Biotechnology Details
2.21.2 Metware Biotechnology Major Business
2.21.3 Metware Biotechnology Blood Proteomics Services Product and Solutions
2.21.4 Metware Biotechnology Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Metware Biotechnology Recent Developments and Future Plans
2.22 MRM Proteomics
2.22.1 MRM Proteomics Details
2.22.2 MRM Proteomics Major Business
2.22.3 MRM Proteomics Blood Proteomics Services Product and Solutions
2.22.4 MRM Proteomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 MRM Proteomics Recent Developments and Future Plans
2.23 Lc-Bio Technologies
2.23.1 Lc-Bio Technologies Details
2.23.2 Lc-Bio Technologies Major Business
2.23.3 Lc-Bio Technologies Blood Proteomics Services Product and Solutions
2.23.4 Lc-Bio Technologies Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 Lc-Bio Technologies Recent Developments and Future Plans
2.24 Eurofins Scientific
2.24.1 Eurofins Scientific Details
2.24.2 Eurofins Scientific Major Business
2.24.3 Eurofins Scientific Blood Proteomics Services Product and Solutions
2.24.4 Eurofins Scientific Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 Eurofins Scientific Recent Developments and Future Plans
2.25 MtoZ-Biolabs
2.25.1 MtoZ-Biolabs Details
2.25.2 MtoZ-Biolabs Major Business
2.25.3 MtoZ-Biolabs Blood Proteomics Services Product and Solutions
2.25.4 MtoZ-Biolabs Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.25.5 MtoZ-Biolabs Recent Developments and Future Plans
2.26 Creative Proteomics
2.26.1 Creative Proteomics Details
2.26.2 Creative Proteomics Major Business
2.26.3 Creative Proteomics Blood Proteomics Services Product and Solutions
2.26.4 Creative Proteomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.26.5 Creative Proteomics Recent Developments and Future Plans
2.27 Macrogen
2.27.1 Macrogen Details
2.27.2 Macrogen Major Business
2.27.3 Macrogen Blood Proteomics Services Product and Solutions
2.27.4 Macrogen Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.27.5 Macrogen Recent Developments and Future Plans
2.28 TATAA Biocenter
2.28.1 TATAA Biocenter Details
2.28.2 TATAA Biocenter Major Business
2.28.3 TATAA Biocenter Blood Proteomics Services Product and Solutions
2.28.4 TATAA Biocenter Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.28.5 TATAA Biocenter Recent Developments and Future Plans
2.29 OmicScouts (Momentum Biotechnologies)
2.29.1 OmicScouts (Momentum Biotechnologies) Details
2.29.2 OmicScouts (Momentum Biotechnologies) Major Business
2.29.3 OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Product and Solutions
2.29.4 OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.29.5 OmicScouts (Momentum Biotechnologies) Recent Developments and Future Plans
2.30 Precision Biomarker Laboratories (PBL)
2.30.1 Precision Biomarker Laboratories (PBL) Details
2.30.2 Precision Biomarker Laboratories (PBL) Major Business
2.30.3 Precision Biomarker Laboratories (PBL) Blood Proteomics Services Product and Solutions
2.30.4 Precision Biomarker Laboratories (PBL) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.30.5 Precision Biomarker Laboratories (PBL) Recent Developments and Future Plans
2.31 Shanghai OE Biotech
2.31.1 Shanghai OE Biotech Details
2.31.2 Shanghai OE Biotech Major Business
2.31.3 Shanghai OE Biotech Blood Proteomics Services Product and Solutions
2.31.4 Shanghai OE Biotech Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.31.5 Shanghai OE Biotech Recent Developments and Future Plans
2.32 RxCelerate
2.32.1 RxCelerate Details
2.32.2 RxCelerate Major Business
2.32.3 RxCelerate Blood Proteomics Services Product and Solutions
2.32.4 RxCelerate Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.32.5 RxCelerate Recent Developments and Future Plans
2.33 Proteomics International
2.33.1 Proteomics International Details
2.33.2 Proteomics International Major Business
2.33.3 Proteomics International Blood Proteomics Services Product and Solutions
2.33.4 Proteomics International Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.33.5 Proteomics International Recent Developments and Future Plans
2.34 Proteome Sciences
2.34.1 Proteome Sciences Details
2.34.2 Proteome Sciences Major Business
2.34.3 Proteome Sciences Blood Proteomics Services Product and Solutions
2.34.4 Proteome Sciences Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.34.5 Proteome Sciences Recent Developments and Future Plans
2.35 Westlake Omics
2.35.1 Westlake Omics Details
2.35.2 Westlake Omics Major Business
2.35.3 Westlake Omics Blood Proteomics Services Product and Solutions
2.35.4 Westlake Omics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.35.5 Westlake Omics Recent Developments and Future Plans
2.36 Crown Bioscience
2.36.1 Crown Bioscience Details
2.36.2 Crown Bioscience Major Business
2.36.3 Crown Bioscience Blood Proteomics Services Product and Solutions
2.36.4 Crown Bioscience Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.36.5 Crown Bioscience Recent Developments and Future Plans
2.37 VProteomics
2.37.1 VProteomics Details
2.37.2 VProteomics Major Business
2.37.3 VProteomics Blood Proteomics Services Product and Solutions
2.37.4 VProteomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.37.5 VProteomics Recent Developments and Future Plans
2.38 Shanghai Majorbio Bio-Pharm
2.38.1 Shanghai Majorbio Bio-Pharm Details
2.38.2 Shanghai Majorbio Bio-Pharm Major Business
2.38.3 Shanghai Majorbio Bio-Pharm Blood Proteomics Services Product and Solutions
2.38.4 Shanghai Majorbio Bio-Pharm Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.38.5 Shanghai Majorbio Bio-Pharm Recent Developments and Future Plans
2.39 Applied Biomics
2.39.1 Applied Biomics Details
2.39.2 Applied Biomics Major Business
2.39.3 Applied Biomics Blood Proteomics Services Product and Solutions
2.39.4 Applied Biomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.39.5 Applied Biomics Recent Developments and Future Plans
2.40 Sapient Bioanalytics
2.40.1 Sapient Bioanalytics Details
2.40.2 Sapient Bioanalytics Major Business
2.40.3 Sapient Bioanalytics Blood Proteomics Services Product and Solutions
2.40.4 Sapient Bioanalytics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
2.40.5 Sapient Bioanalytics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Blood Proteomics Services Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Blood Proteomics Services by Company Revenue
3.2.2 Top 3 Blood Proteomics Services Players Market Share in 2025
3.2.3 Top 6 Blood Proteomics Services Players Market Share in 2025
3.3 Blood Proteomics Services Market: Overall Company Footprint Analysis
3.3.1 Blood Proteomics Services Market: Region Footprint
3.3.2 Blood Proteomics Services Market: Company Product Type Footprint
3.3.3 Blood Proteomics Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Blood Proteomics Services Consumption Value and Market Share by Type (2021-2026)
4.2 Global Blood Proteomics Services Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Blood Proteomics Services Consumption Value Market Share by Application (2021-2026)
5.2 Global Blood Proteomics Services Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Blood Proteomics Services Consumption Value by Type (2021-2032)
6.2 North America Blood Proteomics Services Market Size by Application (2021-2032)
6.3 North America Blood Proteomics Services Market Size by Country
6.3.1 North America Blood Proteomics Services Consumption Value by Country (2021-2032)
6.3.2 United States Blood Proteomics Services Market Size and Forecast (2021-2032)
6.3.3 Canada Blood Proteomics Services Market Size and Forecast (2021-2032)
6.3.4 Mexico Blood Proteomics Services Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Blood Proteomics Services Consumption Value by Type (2021-2032)
7.2 Europe Blood Proteomics Services Consumption Value by Application (2021-2032)
7.3 Europe Blood Proteomics Services Market Size by Country
7.3.1 Europe Blood Proteomics Services Consumption Value by Country (2021-2032)
7.3.2 Germany Blood Proteomics Services Market Size and Forecast (2021-2032)
7.3.3 France Blood Proteomics Services Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Blood Proteomics Services Market Size and Forecast (2021-2032)
7.3.5 Russia Blood Proteomics Services Market Size and Forecast (2021-2032)
7.3.6 Italy Blood Proteomics Services Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Blood Proteomics Services Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Blood Proteomics Services Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Blood Proteomics Services Market Size by Region
8.3.1 Asia-Pacific Blood Proteomics Services Consumption Value by Region (2021-2032)
8.3.2 China Blood Proteomics Services Market Size and Forecast (2021-2032)
8.3.3 Japan Blood Proteomics Services Market Size and Forecast (2021-2032)
8.3.4 South Korea Blood Proteomics Services Market Size and Forecast (2021-2032)
8.3.5 India Blood Proteomics Services Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Blood Proteomics Services Market Size and Forecast (2021-2032)
8.3.7 Australia Blood Proteomics Services Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Blood Proteomics Services Consumption Value by Type (2021-2032)
9.2 South America Blood Proteomics Services Consumption Value by Application (2021-2032)
9.3 South America Blood Proteomics Services Market Size by Country
9.3.1 South America Blood Proteomics Services Consumption Value by Country (2021-2032)
9.3.2 Brazil Blood Proteomics Services Market Size and Forecast (2021-2032)
9.3.3 Argentina Blood Proteomics Services Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Blood Proteomics Services Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Blood Proteomics Services Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Blood Proteomics Services Market Size by Country
10.3.1 Middle East & Africa Blood Proteomics Services Consumption Value by Country (2021-2032)
10.3.2 Turkey Blood Proteomics Services Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Blood Proteomics Services Market Size and Forecast (2021-2032)
10.3.4 UAE Blood Proteomics Services Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Blood Proteomics Services Market Drivers
11.2 Blood Proteomics Services Market Restraints
11.3 Blood Proteomics Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Blood Proteomics Services Industry Chain
12.2 Blood Proteomics Services Upstream Analysis
12.3 Blood Proteomics Services Midstream Analysis
12.4 Blood Proteomics Services Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Blood Proteomics Services Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Blood Proteomics Services Consumption Value by End User, (USD Million), 2021 & 2025 & 2032
Table 3. Global Blood Proteomics Services Consumption Value by Research Areas, (USD Million), 2021 & 2025 & 2032
Table 4. Global Blood Proteomics Services Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Blood Proteomics Services Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Blood Proteomics Services Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Olink (Thermo Fisher Scientific) Company Information, Head Office, and Major Competitors
Table 8. Olink (Thermo Fisher Scientific) Major Business
Table 9. Olink (Thermo Fisher Scientific) Blood Proteomics Services Product and Solutions
Table 10. Olink (Thermo Fisher Scientific) Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Olink (Thermo Fisher Scientific) Recent Developments and Future Plans
Table 12. SomaLogic (Illumina) Company Information, Head Office, and Major Competitors
Table 13. SomaLogic (Illumina) Major Business
Table 14. SomaLogic (Illumina) Blood Proteomics Services Product and Solutions
Table 15. SomaLogic (Illumina) Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. SomaLogic (Illumina) Recent Developments and Future Plans
Table 17. Labcorp Company Information, Head Office, and Major Competitors
Table 18. Labcorp Major Business
Table 19. Labcorp Blood Proteomics Services Product and Solutions
Table 20. Labcorp Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. BostonGene Company Information, Head Office, and Major Competitors
Table 22. BostonGene Major Business
Table 23. BostonGene Blood Proteomics Services Product and Solutions
Table 24. BostonGene Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. BostonGene Recent Developments and Future Plans
Table 26. CellCarta Company Information, Head Office, and Major Competitors
Table 27. CellCarta Major Business
Table 28. CellCarta Blood Proteomics Services Product and Solutions
Table 29. CellCarta Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. CellCarta Recent Developments and Future Plans
Table 31. GENEWIZ (Azenta Life Sciences) Company Information, Head Office, and Major Competitors
Table 32. GENEWIZ (Azenta Life Sciences) Major Business
Table 33. GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Product and Solutions
Table 34. GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. GENEWIZ (Azenta Life Sciences) Recent Developments and Future Plans
Table 36. CDI Labs Company Information, Head Office, and Major Competitors
Table 37. CDI Labs Major Business
Table 38. CDI Labs Blood Proteomics Services Product and Solutions
Table 39. CDI Labs Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. CDI Labs Recent Developments and Future Plans
Table 41. Biognosys Company Information, Head Office, and Major Competitors
Table 42. Biognosys Major Business
Table 43. Biognosys Blood Proteomics Services Product and Solutions
Table 44. Biognosys Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Biognosys Recent Developments and Future Plans
Table 46. Discovery Life Sciences Company Information, Head Office, and Major Competitors
Table 47. Discovery Life Sciences Major Business
Table 48. Discovery Life Sciences Blood Proteomics Services Product and Solutions
Table 49. Discovery Life Sciences Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Discovery Life Sciences Recent Developments and Future Plans
Table 51. Firalis Molecular Precision Company Information, Head Office, and Major Competitors
Table 52. Firalis Molecular Precision Major Business
Table 53. Firalis Molecular Precision Blood Proteomics Services Product and Solutions
Table 54. Firalis Molecular Precision Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Firalis Molecular Precision Recent Developments and Future Plans
Table 56. Cell Signaling Technology (CST) Company Information, Head Office, and Major Competitors
Table 57. Cell Signaling Technology (CST) Major Business
Table 58. Cell Signaling Technology (CST) Blood Proteomics Services Product and Solutions
Table 59. Cell Signaling Technology (CST) Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Cell Signaling Technology (CST) Recent Developments and Future Plans
Table 61. Sampled (Infinity Biologix) Company Information, Head Office, and Major Competitors
Table 62. Sampled (Infinity Biologix) Major Business
Table 63. Sampled (Infinity Biologix) Blood Proteomics Services Product and Solutions
Table 64. Sampled (Infinity Biologix) Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Sampled (Infinity Biologix) Recent Developments and Future Plans
Table 66. APTBIO Company Information, Head Office, and Major Competitors
Table 67. APTBIO Major Business
Table 68. APTBIO Blood Proteomics Services Product and Solutions
Table 69. APTBIO Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. APTBIO Recent Developments and Future Plans
Table 71. Sinotech Genomics Company Information, Head Office, and Major Competitors
Table 72. Sinotech Genomics Major Business
Table 73. Sinotech Genomics Blood Proteomics Services Product and Solutions
Table 74. Sinotech Genomics Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Sinotech Genomics Recent Developments and Future Plans
Table 76. Biodesix Company Information, Head Office, and Major Competitors
Table 77. Biodesix Major Business
Table 78. Biodesix Blood Proteomics Services Product and Solutions
Table 79. Biodesix Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Biodesix Recent Developments and Future Plans
Table 81. Panome Bio Company Information, Head Office, and Major Competitors
Table 82. Panome Bio Major Business
Table 83. Panome Bio Blood Proteomics Services Product and Solutions
Table 84. Panome Bio Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Panome Bio Recent Developments and Future Plans
Table 86. Novogene Company Information, Head Office, and Major Competitors
Table 87. Novogene Major Business
Table 88. Novogene Blood Proteomics Services Product and Solutions
Table 89. Novogene Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Novogene Recent Developments and Future Plans
Table 91. PTM BIO Company Information, Head Office, and Major Competitors
Table 92. PTM BIO Major Business
Table 93. PTM BIO Blood Proteomics Services Product and Solutions
Table 94. PTM BIO Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. PTM BIO Recent Developments and Future Plans
Table 96. BGI Genomics Company Information, Head Office, and Major Competitors
Table 97. BGI Genomics Major Business
Table 98. BGI Genomics Blood Proteomics Services Product and Solutions
Table 99. BGI Genomics Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. BGI Genomics Recent Developments and Future Plans
Table 101. Evotec Company Information, Head Office, and Major Competitors
Table 102. Evotec Major Business
Table 103. Evotec Blood Proteomics Services Product and Solutions
Table 104. Evotec Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 105. Evotec Recent Developments and Future Plans
Table 106. Metware Biotechnology Company Information, Head Office, and Major Competitors
Table 107. Metware Biotechnology Major Business
Table 108. Metware Biotechnology Blood Proteomics Services Product and Solutions
Table 109. Metware Biotechnology Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Metware Biotechnology Recent Developments and Future Plans
Table 111. MRM Proteomics Company Information, Head Office, and Major Competitors
Table 112. MRM Proteomics Major Business
Table 113. MRM Proteomics Blood Proteomics Services Product and Solutions
Table 114. MRM Proteomics Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. MRM Proteomics Recent Developments and Future Plans
Table 116. Lc-Bio Technologies Company Information, Head Office, and Major Competitors
Table 117. Lc-Bio Technologies Major Business
Table 118. Lc-Bio Technologies Blood Proteomics Services Product and Solutions
Table 119. Lc-Bio Technologies Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Lc-Bio Technologies Recent Developments and Future Plans
Table 121. Eurofins Scientific Company Information, Head Office, and Major Competitors
Table 122. Eurofins Scientific Major Business
Table 123. Eurofins Scientific Blood Proteomics Services Product and Solutions
Table 124. Eurofins Scientific Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Eurofins Scientific Recent Developments and Future Plans
Table 126. MtoZ-Biolabs Company Information, Head Office, and Major Competitors
Table 127. MtoZ-Biolabs Major Business
Table 128. MtoZ-Biolabs Blood Proteomics Services Product and Solutions
Table 129. MtoZ-Biolabs Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 130. MtoZ-Biolabs Recent Developments and Future Plans
Table 131. Creative Proteomics Company Information, Head Office, and Major Competitors
Table 132. Creative Proteomics Major Business
Table 133. Creative Proteomics Blood Proteomics Services Product and Solutions
Table 134. Creative Proteomics Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 135. Creative Proteomics Recent Developments and Future Plans
Table 136. Macrogen Company Information, Head Office, and Major Competitors
Table 137. Macrogen Major Business
Table 138. Macrogen Blood Proteomics Services Product and Solutions
Table 139. Macrogen Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 140. Macrogen Recent Developments and Future Plans
Table 141. TATAA Biocenter Company Information, Head Office, and Major Competitors
Table 142. TATAA Biocenter Major Business
Table 143. TATAA Biocenter Blood Proteomics Services Product and Solutions
Table 144. TATAA Biocenter Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. TATAA Biocenter Recent Developments and Future Plans
Table 146. OmicScouts (Momentum Biotechnologies) Company Information, Head Office, and Major Competitors
Table 147. OmicScouts (Momentum Biotechnologies) Major Business
Table 148. OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Product and Solutions
Table 149. OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 150. OmicScouts (Momentum Biotechnologies) Recent Developments and Future Plans
Table 151. Precision Biomarker Laboratories (PBL) Company Information, Head Office, and Major Competitors
Table 152. Precision Biomarker Laboratories (PBL) Major Business
Table 153. Precision Biomarker Laboratories (PBL) Blood Proteomics Services Product and Solutions
Table 154. Precision Biomarker Laboratories (PBL) Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 155. Precision Biomarker Laboratories (PBL) Recent Developments and Future Plans
Table 156. Shanghai OE Biotech Company Information, Head Office, and Major Competitors
Table 157. Shanghai OE Biotech Major Business
Table 158. Shanghai OE Biotech Blood Proteomics Services Product and Solutions
Table 159. Shanghai OE Biotech Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 160. Shanghai OE Biotech Recent Developments and Future Plans
Table 161. RxCelerate Company Information, Head Office, and Major Competitors
Table 162. RxCelerate Major Business
Table 163. RxCelerate Blood Proteomics Services Product and Solutions
Table 164. RxCelerate Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 165. RxCelerate Recent Developments and Future Plans
Table 166. Proteomics International Company Information, Head Office, and Major Competitors
Table 167. Proteomics International Major Business
Table 168. Proteomics International Blood Proteomics Services Product and Solutions
Table 169. Proteomics International Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 170. Proteomics International Recent Developments and Future Plans
Table 171. Proteome Sciences Company Information, Head Office, and Major Competitors
Table 172. Proteome Sciences Major Business
Table 173. Proteome Sciences Blood Proteomics Services Product and Solutions
Table 174. Proteome Sciences Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Proteome Sciences Recent Developments and Future Plans
Table 176. Westlake Omics Company Information, Head Office, and Major Competitors
Table 177. Westlake Omics Major Business
Table 178. Westlake Omics Blood Proteomics Services Product and Solutions
Table 179. Westlake Omics Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 180. Westlake Omics Recent Developments and Future Plans
Table 181. Crown Bioscience Company Information, Head Office, and Major Competitors
Table 182. Crown Bioscience Major Business
Table 183. Crown Bioscience Blood Proteomics Services Product and Solutions
Table 184. Crown Bioscience Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 185. Crown Bioscience Recent Developments and Future Plans
Table 186. VProteomics Company Information, Head Office, and Major Competitors
Table 187. VProteomics Major Business
Table 188. VProteomics Blood Proteomics Services Product and Solutions
Table 189. VProteomics Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 190. VProteomics Recent Developments and Future Plans
Table 191. Shanghai Majorbio Bio-Pharm Company Information, Head Office, and Major Competitors
Table 192. Shanghai Majorbio Bio-Pharm Major Business
Table 193. Shanghai Majorbio Bio-Pharm Blood Proteomics Services Product and Solutions
Table 194. Shanghai Majorbio Bio-Pharm Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 195. Shanghai Majorbio Bio-Pharm Recent Developments and Future Plans
Table 196. Applied Biomics Company Information, Head Office, and Major Competitors
Table 197. Applied Biomics Major Business
Table 198. Applied Biomics Blood Proteomics Services Product and Solutions
Table 199. Applied Biomics Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 200. Applied Biomics Recent Developments and Future Plans
Table 201. Sapient Bioanalytics Company Information, Head Office, and Major Competitors
Table 202. Sapient Bioanalytics Major Business
Table 203. Sapient Bioanalytics Blood Proteomics Services Product and Solutions
Table 204. Sapient Bioanalytics Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 205. Sapient Bioanalytics Recent Developments and Future Plans
Table 206. Global Blood Proteomics Services Revenue (USD Million) by Players (2021-2026)
Table 207. Global Blood Proteomics Services Revenue Share by Players (2021-2026)
Table 208. Breakdown of Blood Proteomics Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 209. Market Position of Players in Blood Proteomics Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 210. Head Office of Key Blood Proteomics Services Players
Table 211. Blood Proteomics Services Market: Company Product Type Footprint
Table 212. Blood Proteomics Services Market: Company Product Application Footprint
Table 213. Blood Proteomics Services New Market Entrants and Barriers to Market Entry
Table 214. Blood Proteomics Services Mergers, Acquisition, Agreements, and Collaborations
Table 215. Global Blood Proteomics Services Consumption Value (USD Million) by Type (2021-2026)
Table 216. Global Blood Proteomics Services Consumption Value Share by Type (2021-2026)
Table 217. Global Blood Proteomics Services Consumption Value Forecast by Type (2027-2032)
Table 218. Global Blood Proteomics Services Consumption Value by Application (2021-2026)
Table 219. Global Blood Proteomics Services Consumption Value Forecast by Application (2027-2032)
Table 220. North America Blood Proteomics Services Consumption Value by Type (2021-2026) & (USD Million)
Table 221. North America Blood Proteomics Services Consumption Value by Type (2027-2032) & (USD Million)
Table 222. North America Blood Proteomics Services Consumption Value by Application (2021-2026) & (USD Million)
Table 223. North America Blood Proteomics Services Consumption Value by Application (2027-2032) & (USD Million)
Table 224. North America Blood Proteomics Services Consumption Value by Country (2021-2026) & (USD Million)
Table 225. North America Blood Proteomics Services Consumption Value by Country (2027-2032) & (USD Million)
Table 226. Europe Blood Proteomics Services Consumption Value by Type (2021-2026) & (USD Million)
Table 227. Europe Blood Proteomics Services Consumption Value by Type (2027-2032) & (USD Million)
Table 228. Europe Blood Proteomics Services Consumption Value by Application (2021-2026) & (USD Million)
Table 229. Europe Blood Proteomics Services Consumption Value by Application (2027-2032) & (USD Million)
Table 230. Europe Blood Proteomics Services Consumption Value by Country (2021-2026) & (USD Million)
Table 231. Europe Blood Proteomics Services Consumption Value by Country (2027-2032) & (USD Million)
Table 232. Asia-Pacific Blood Proteomics Services Consumption Value by Type (2021-2026) & (USD Million)
Table 233. Asia-Pacific Blood Proteomics Services Consumption Value by Type (2027-2032) & (USD Million)
Table 234. Asia-Pacific Blood Proteomics Services Consumption Value by Application (2021-2026) & (USD Million)
Table 235. Asia-Pacific Blood Proteomics Services Consumption Value by Application (2027-2032) & (USD Million)
Table 236. Asia-Pacific Blood Proteomics Services Consumption Value by Region (2021-2026) & (USD Million)
Table 237. Asia-Pacific Blood Proteomics Services Consumption Value by Region (2027-2032) & (USD Million)
Table 238. South America Blood Proteomics Services Consumption Value by Type (2021-2026) & (USD Million)
Table 239. South America Blood Proteomics Services Consumption Value by Type (2027-2032) & (USD Million)
Table 240. South America Blood Proteomics Services Consumption Value by Application (2021-2026) & (USD Million)
Table 241. South America Blood Proteomics Services Consumption Value by Application (2027-2032) & (USD Million)
Table 242. South America Blood Proteomics Services Consumption Value by Country (2021-2026) & (USD Million)
Table 243. South America Blood Proteomics Services Consumption Value by Country (2027-2032) & (USD Million)
Table 244. Middle East & Africa Blood Proteomics Services Consumption Value by Type (2021-2026) & (USD Million)
Table 245. Middle East & Africa Blood Proteomics Services Consumption Value by Type (2027-2032) & (USD Million)
Table 246. Middle East & Africa Blood Proteomics Services Consumption Value by Application (2021-2026) & (USD Million)
Table 247. Middle East & Africa Blood Proteomics Services Consumption Value by Application (2027-2032) & (USD Million)
Table 248. Middle East & Africa Blood Proteomics Services Consumption Value by Country (2021-2026) & (USD Million)
Table 249. Middle East & Africa Blood Proteomics Services Consumption Value by Country (2027-2032) & (USD Million)
Table 250. Global Key Players of Blood Proteomics Services Upstream (Raw Materials)
Table 251. Global Blood Proteomics Services Typical Customers
Table 1. Global Blood Proteomics Services Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Blood Proteomics Services Consumption Value by End User, (USD Million), 2021 & 2025 & 2032
Table 3. Global Blood Proteomics Services Consumption Value by Research Areas, (USD Million), 2021 & 2025 & 2032
Table 4. Global Blood Proteomics Services Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Blood Proteomics Services Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Blood Proteomics Services Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Olink (Thermo Fisher Scientific) Company Information, Head Office, and Major Competitors
Table 8. Olink (Thermo Fisher Scientific) Major Business
Table 9. Olink (Thermo Fisher Scientific) Blood Proteomics Services Product and Solutions
Table 10. Olink (Thermo Fisher Scientific) Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Olink (Thermo Fisher Scientific) Recent Developments and Future Plans
Table 12. SomaLogic (Illumina) Company Information, Head Office, and Major Competitors
Table 13. SomaLogic (Illumina) Major Business
Table 14. SomaLogic (Illumina) Blood Proteomics Services Product and Solutions
Table 15. SomaLogic (Illumina) Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. SomaLogic (Illumina) Recent Developments and Future Plans
Table 17. Labcorp Company Information, Head Office, and Major Competitors
Table 18. Labcorp Major Business
Table 19. Labcorp Blood Proteomics Services Product and Solutions
Table 20. Labcorp Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. BostonGene Company Information, Head Office, and Major Competitors
Table 22. BostonGene Major Business
Table 23. BostonGene Blood Proteomics Services Product and Solutions
Table 24. BostonGene Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. BostonGene Recent Developments and Future Plans
Table 26. CellCarta Company Information, Head Office, and Major Competitors
Table 27. CellCarta Major Business
Table 28. CellCarta Blood Proteomics Services Product and Solutions
Table 29. CellCarta Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. CellCarta Recent Developments and Future Plans
Table 31. GENEWIZ (Azenta Life Sciences) Company Information, Head Office, and Major Competitors
Table 32. GENEWIZ (Azenta Life Sciences) Major Business
Table 33. GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Product and Solutions
Table 34. GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. GENEWIZ (Azenta Life Sciences) Recent Developments and Future Plans
Table 36. CDI Labs Company Information, Head Office, and Major Competitors
Table 37. CDI Labs Major Business
Table 38. CDI Labs Blood Proteomics Services Product and Solutions
Table 39. CDI Labs Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. CDI Labs Recent Developments and Future Plans
Table 41. Biognosys Company Information, Head Office, and Major Competitors
Table 42. Biognosys Major Business
Table 43. Biognosys Blood Proteomics Services Product and Solutions
Table 44. Biognosys Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Biognosys Recent Developments and Future Plans
Table 46. Discovery Life Sciences Company Information, Head Office, and Major Competitors
Table 47. Discovery Life Sciences Major Business
Table 48. Discovery Life Sciences Blood Proteomics Services Product and Solutions
Table 49. Discovery Life Sciences Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Discovery Life Sciences Recent Developments and Future Plans
Table 51. Firalis Molecular Precision Company Information, Head Office, and Major Competitors
Table 52. Firalis Molecular Precision Major Business
Table 53. Firalis Molecular Precision Blood Proteomics Services Product and Solutions
Table 54. Firalis Molecular Precision Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Firalis Molecular Precision Recent Developments and Future Plans
Table 56. Cell Signaling Technology (CST) Company Information, Head Office, and Major Competitors
Table 57. Cell Signaling Technology (CST) Major Business
Table 58. Cell Signaling Technology (CST) Blood Proteomics Services Product and Solutions
Table 59. Cell Signaling Technology (CST) Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Cell Signaling Technology (CST) Recent Developments and Future Plans
Table 61. Sampled (Infinity Biologix) Company Information, Head Office, and Major Competitors
Table 62. Sampled (Infinity Biologix) Major Business
Table 63. Sampled (Infinity Biologix) Blood Proteomics Services Product and Solutions
Table 64. Sampled (Infinity Biologix) Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Sampled (Infinity Biologix) Recent Developments and Future Plans
Table 66. APTBIO Company Information, Head Office, and Major Competitors
Table 67. APTBIO Major Business
Table 68. APTBIO Blood Proteomics Services Product and Solutions
Table 69. APTBIO Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. APTBIO Recent Developments and Future Plans
Table 71. Sinotech Genomics Company Information, Head Office, and Major Competitors
Table 72. Sinotech Genomics Major Business
Table 73. Sinotech Genomics Blood Proteomics Services Product and Solutions
Table 74. Sinotech Genomics Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Sinotech Genomics Recent Developments and Future Plans
Table 76. Biodesix Company Information, Head Office, and Major Competitors
Table 77. Biodesix Major Business
Table 78. Biodesix Blood Proteomics Services Product and Solutions
Table 79. Biodesix Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Biodesix Recent Developments and Future Plans
Table 81. Panome Bio Company Information, Head Office, and Major Competitors
Table 82. Panome Bio Major Business
Table 83. Panome Bio Blood Proteomics Services Product and Solutions
Table 84. Panome Bio Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Panome Bio Recent Developments and Future Plans
Table 86. Novogene Company Information, Head Office, and Major Competitors
Table 87. Novogene Major Business
Table 88. Novogene Blood Proteomics Services Product and Solutions
Table 89. Novogene Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Novogene Recent Developments and Future Plans
Table 91. PTM BIO Company Information, Head Office, and Major Competitors
Table 92. PTM BIO Major Business
Table 93. PTM BIO Blood Proteomics Services Product and Solutions
Table 94. PTM BIO Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. PTM BIO Recent Developments and Future Plans
Table 96. BGI Genomics Company Information, Head Office, and Major Competitors
Table 97. BGI Genomics Major Business
Table 98. BGI Genomics Blood Proteomics Services Product and Solutions
Table 99. BGI Genomics Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. BGI Genomics Recent Developments and Future Plans
Table 101. Evotec Company Information, Head Office, and Major Competitors
Table 102. Evotec Major Business
Table 103. Evotec Blood Proteomics Services Product and Solutions
Table 104. Evotec Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 105. Evotec Recent Developments and Future Plans
Table 106. Metware Biotechnology Company Information, Head Office, and Major Competitors
Table 107. Metware Biotechnology Major Business
Table 108. Metware Biotechnology Blood Proteomics Services Product and Solutions
Table 109. Metware Biotechnology Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Metware Biotechnology Recent Developments and Future Plans
Table 111. MRM Proteomics Company Information, Head Office, and Major Competitors
Table 112. MRM Proteomics Major Business
Table 113. MRM Proteomics Blood Proteomics Services Product and Solutions
Table 114. MRM Proteomics Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. MRM Proteomics Recent Developments and Future Plans
Table 116. Lc-Bio Technologies Company Information, Head Office, and Major Competitors
Table 117. Lc-Bio Technologies Major Business
Table 118. Lc-Bio Technologies Blood Proteomics Services Product and Solutions
Table 119. Lc-Bio Technologies Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Lc-Bio Technologies Recent Developments and Future Plans
Table 121. Eurofins Scientific Company Information, Head Office, and Major Competitors
Table 122. Eurofins Scientific Major Business
Table 123. Eurofins Scientific Blood Proteomics Services Product and Solutions
Table 124. Eurofins Scientific Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Eurofins Scientific Recent Developments and Future Plans
Table 126. MtoZ-Biolabs Company Information, Head Office, and Major Competitors
Table 127. MtoZ-Biolabs Major Business
Table 128. MtoZ-Biolabs Blood Proteomics Services Product and Solutions
Table 129. MtoZ-Biolabs Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 130. MtoZ-Biolabs Recent Developments and Future Plans
Table 131. Creative Proteomics Company Information, Head Office, and Major Competitors
Table 132. Creative Proteomics Major Business
Table 133. Creative Proteomics Blood Proteomics Services Product and Solutions
Table 134. Creative Proteomics Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 135. Creative Proteomics Recent Developments and Future Plans
Table 136. Macrogen Company Information, Head Office, and Major Competitors
Table 137. Macrogen Major Business
Table 138. Macrogen Blood Proteomics Services Product and Solutions
Table 139. Macrogen Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 140. Macrogen Recent Developments and Future Plans
Table 141. TATAA Biocenter Company Information, Head Office, and Major Competitors
Table 142. TATAA Biocenter Major Business
Table 143. TATAA Biocenter Blood Proteomics Services Product and Solutions
Table 144. TATAA Biocenter Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. TATAA Biocenter Recent Developments and Future Plans
Table 146. OmicScouts (Momentum Biotechnologies) Company Information, Head Office, and Major Competitors
Table 147. OmicScouts (Momentum Biotechnologies) Major Business
Table 148. OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Product and Solutions
Table 149. OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 150. OmicScouts (Momentum Biotechnologies) Recent Developments and Future Plans
Table 151. Precision Biomarker Laboratories (PBL) Company Information, Head Office, and Major Competitors
Table 152. Precision Biomarker Laboratories (PBL) Major Business
Table 153. Precision Biomarker Laboratories (PBL) Blood Proteomics Services Product and Solutions
Table 154. Precision Biomarker Laboratories (PBL) Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 155. Precision Biomarker Laboratories (PBL) Recent Developments and Future Plans
Table 156. Shanghai OE Biotech Company Information, Head Office, and Major Competitors
Table 157. Shanghai OE Biotech Major Business
Table 158. Shanghai OE Biotech Blood Proteomics Services Product and Solutions
Table 159. Shanghai OE Biotech Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 160. Shanghai OE Biotech Recent Developments and Future Plans
Table 161. RxCelerate Company Information, Head Office, and Major Competitors
Table 162. RxCelerate Major Business
Table 163. RxCelerate Blood Proteomics Services Product and Solutions
Table 164. RxCelerate Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 165. RxCelerate Recent Developments and Future Plans
Table 166. Proteomics International Company Information, Head Office, and Major Competitors
Table 167. Proteomics International Major Business
Table 168. Proteomics International Blood Proteomics Services Product and Solutions
Table 169. Proteomics International Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 170. Proteomics International Recent Developments and Future Plans
Table 171. Proteome Sciences Company Information, Head Office, and Major Competitors
Table 172. Proteome Sciences Major Business
Table 173. Proteome Sciences Blood Proteomics Services Product and Solutions
Table 174. Proteome Sciences Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Proteome Sciences Recent Developments and Future Plans
Table 176. Westlake Omics Company Information, Head Office, and Major Competitors
Table 177. Westlake Omics Major Business
Table 178. Westlake Omics Blood Proteomics Services Product and Solutions
Table 179. Westlake Omics Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 180. Westlake Omics Recent Developments and Future Plans
Table 181. Crown Bioscience Company Information, Head Office, and Major Competitors
Table 182. Crown Bioscience Major Business
Table 183. Crown Bioscience Blood Proteomics Services Product and Solutions
Table 184. Crown Bioscience Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 185. Crown Bioscience Recent Developments and Future Plans
Table 186. VProteomics Company Information, Head Office, and Major Competitors
Table 187. VProteomics Major Business
Table 188. VProteomics Blood Proteomics Services Product and Solutions
Table 189. VProteomics Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 190. VProteomics Recent Developments and Future Plans
Table 191. Shanghai Majorbio Bio-Pharm Company Information, Head Office, and Major Competitors
Table 192. Shanghai Majorbio Bio-Pharm Major Business
Table 193. Shanghai Majorbio Bio-Pharm Blood Proteomics Services Product and Solutions
Table 194. Shanghai Majorbio Bio-Pharm Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 195. Shanghai Majorbio Bio-Pharm Recent Developments and Future Plans
Table 196. Applied Biomics Company Information, Head Office, and Major Competitors
Table 197. Applied Biomics Major Business
Table 198. Applied Biomics Blood Proteomics Services Product and Solutions
Table 199. Applied Biomics Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 200. Applied Biomics Recent Developments and Future Plans
Table 201. Sapient Bioanalytics Company Information, Head Office, and Major Competitors
Table 202. Sapient Bioanalytics Major Business
Table 203. Sapient Bioanalytics Blood Proteomics Services Product and Solutions
Table 204. Sapient Bioanalytics Blood Proteomics Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 205. Sapient Bioanalytics Recent Developments and Future Plans
Table 206. Global Blood Proteomics Services Revenue (USD Million) by Players (2021-2026)
Table 207. Global Blood Proteomics Services Revenue Share by Players (2021-2026)
Table 208. Breakdown of Blood Proteomics Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 209. Market Position of Players in Blood Proteomics Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 210. Head Office of Key Blood Proteomics Services Players
Table 211. Blood Proteomics Services Market: Company Product Type Footprint
Table 212. Blood Proteomics Services Market: Company Product Application Footprint
Table 213. Blood Proteomics Services New Market Entrants and Barriers to Market Entry
Table 214. Blood Proteomics Services Mergers, Acquisition, Agreements, and Collaborations
Table 215. Global Blood Proteomics Services Consumption Value (USD Million) by Type (2021-2026)
Table 216. Global Blood Proteomics Services Consumption Value Share by Type (2021-2026)
Table 217. Global Blood Proteomics Services Consumption Value Forecast by Type (2027-2032)
Table 218. Global Blood Proteomics Services Consumption Value by Application (2021-2026)
Table 219. Global Blood Proteomics Services Consumption Value Forecast by Application (2027-2032)
Table 220. North America Blood Proteomics Services Consumption Value by Type (2021-2026) & (USD Million)
Table 221. North America Blood Proteomics Services Consumption Value by Type (2027-2032) & (USD Million)
Table 222. North America Blood Proteomics Services Consumption Value by Application (2021-2026) & (USD Million)
Table 223. North America Blood Proteomics Services Consumption Value by Application (2027-2032) & (USD Million)
Table 224. North America Blood Proteomics Services Consumption Value by Country (2021-2026) & (USD Million)
Table 225. North America Blood Proteomics Services Consumption Value by Country (2027-2032) & (USD Million)
Table 226. Europe Blood Proteomics Services Consumption Value by Type (2021-2026) & (USD Million)
Table 227. Europe Blood Proteomics Services Consumption Value by Type (2027-2032) & (USD Million)
Table 228. Europe Blood Proteomics Services Consumption Value by Application (2021-2026) & (USD Million)
Table 229. Europe Blood Proteomics Services Consumption Value by Application (2027-2032) & (USD Million)
Table 230. Europe Blood Proteomics Services Consumption Value by Country (2021-2026) & (USD Million)
Table 231. Europe Blood Proteomics Services Consumption Value by Country (2027-2032) & (USD Million)
Table 232. Asia-Pacific Blood Proteomics Services Consumption Value by Type (2021-2026) & (USD Million)
Table 233. Asia-Pacific Blood Proteomics Services Consumption Value by Type (2027-2032) & (USD Million)
Table 234. Asia-Pacific Blood Proteomics Services Consumption Value by Application (2021-2026) & (USD Million)
Table 235. Asia-Pacific Blood Proteomics Services Consumption Value by Application (2027-2032) & (USD Million)
Table 236. Asia-Pacific Blood Proteomics Services Consumption Value by Region (2021-2026) & (USD Million)
Table 237. Asia-Pacific Blood Proteomics Services Consumption Value by Region (2027-2032) & (USD Million)
Table 238. South America Blood Proteomics Services Consumption Value by Type (2021-2026) & (USD Million)
Table 239. South America Blood Proteomics Services Consumption Value by Type (2027-2032) & (USD Million)
Table 240. South America Blood Proteomics Services Consumption Value by Application (2021-2026) & (USD Million)
Table 241. South America Blood Proteomics Services Consumption Value by Application (2027-2032) & (USD Million)
Table 242. South America Blood Proteomics Services Consumption Value by Country (2021-2026) & (USD Million)
Table 243. South America Blood Proteomics Services Consumption Value by Country (2027-2032) & (USD Million)
Table 244. Middle East & Africa Blood Proteomics Services Consumption Value by Type (2021-2026) & (USD Million)
Table 245. Middle East & Africa Blood Proteomics Services Consumption Value by Type (2027-2032) & (USD Million)
Table 246. Middle East & Africa Blood Proteomics Services Consumption Value by Application (2021-2026) & (USD Million)
Table 247. Middle East & Africa Blood Proteomics Services Consumption Value by Application (2027-2032) & (USD Million)
Table 248. Middle East & Africa Blood Proteomics Services Consumption Value by Country (2021-2026) & (USD Million)
Table 249. Middle East & Africa Blood Proteomics Services Consumption Value by Country (2027-2032) & (USD Million)
Table 250. Global Key Players of Blood Proteomics Services Upstream (Raw Materials)
Table 251. Global Blood Proteomics Services Typical Customers
LIST OF FIGURES
Figure 1. Blood Proteomics Services Picture
Figure 2. Global Blood Proteomics Services Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Blood Proteomics Services Consumption Value Market Share by Type in 2025
Figure 4. Blood Proteomics
Figure 5. Blood Modification Proteomics
Figure 6. Olink (Targeted) Proteomics
Figure 7. Global Blood Proteomics Services Consumption Value by End User, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Blood Proteomics Services Consumption Value Market Share by End User in 2025
Figure 9. Universities and Research Institutes
Figure 10. Hospitals
Figure 11. Pharmaceutical Companies
Figure 12. Others
Figure 13. Global Blood Proteomics Services Consumption Value by Research Areas, (USD Million), 2021 & 2025 & 2032
Figure 14. Global Blood Proteomics Services Consumption Value Market Share by Research Areas in 2025
Figure 15. Oncology
Figure 16. Cardiovascular
Figure 17. Agriculture
Figure 18. Neuroscience
Figure 19. Other
Figure 20. Global Blood Proteomics Services Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 21. Blood Proteomics Services Consumption Value Market Share by Application in 2025
Figure 22. Disease Biomarker Research Picture
Figure 23. Drug Development Picture
Figure 24. Clinical Research Picture
Figure 25. Others Picture
Figure 26. Global Blood Proteomics Services Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 27. Global Blood Proteomics Services Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 28. Global Market Blood Proteomics Services Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 29. Global Blood Proteomics Services Consumption Value Market Share by Region (2021-2032)
Figure 30. Global Blood Proteomics Services Consumption Value Market Share by Region in 2025
Figure 31. North America Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 32. Europe Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 33. Asia-Pacific Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 34. South America Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 35. Middle East & Africa Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 36. Company Three Recent Developments and Future Plans
Figure 37. Global Blood Proteomics Services Revenue Share by Players in 2025
Figure 38. Blood Proteomics Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 39. Market Share of Blood Proteomics Services by Player Revenue in 2025
Figure 40. Top 3 Blood Proteomics Services Players Market Share in 2025
Figure 41. Top 6 Blood Proteomics Services Players Market Share in 2025
Figure 42. Global Blood Proteomics Services Consumption Value Share by Type (2021-2026)
Figure 43. Global Blood Proteomics Services Market Share Forecast by Type (2027-2032)
Figure 44. Global Blood Proteomics Services Consumption Value Share by Application (2021-2026)
Figure 45. Global Blood Proteomics Services Market Share Forecast by Application (2027-2032)
Figure 46. North America Blood Proteomics Services Consumption Value Market Share by Type (2021-2032)
Figure 47. North America Blood Proteomics Services Consumption Value Market Share by Application (2021-2032)
Figure 48. North America Blood Proteomics Services Consumption Value Market Share by Country (2021-2032)
Figure 49. United States Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 50. Canada Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 51. Mexico Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 52. Europe Blood Proteomics Services Consumption Value Market Share by Type (2021-2032)
Figure 53. Europe Blood Proteomics Services Consumption Value Market Share by Application (2021-2032)
Figure 54. Europe Blood Proteomics Services Consumption Value Market Share by Country (2021-2032)
Figure 55. Germany Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 56. France Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 57. United Kingdom Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 58. Russia Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 59. Italy Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 60. Asia-Pacific Blood Proteomics Services Consumption Value Market Share by Type (2021-2032)
Figure 61. Asia-Pacific Blood Proteomics Services Consumption Value Market Share by Application (2021-2032)
Figure 62. Asia-Pacific Blood Proteomics Services Consumption Value Market Share by Region (2021-2032)
Figure 63. China Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 64. Japan Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 65. South Korea Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 66. India Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 67. Southeast Asia Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 68. Australia Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 69. South America Blood Proteomics Services Consumption Value Market Share by Type (2021-2032)
Figure 70. South America Blood Proteomics Services Consumption Value Market Share by Application (2021-2032)
Figure 71. South America Blood Proteomics Services Consumption Value Market Share by Country (2021-2032)
Figure 72. Brazil Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 73. Argentina Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 74. Middle East & Africa Blood Proteomics Services Consumption Value Market Share by Type (2021-2032)
Figure 75. Middle East & Africa Blood Proteomics Services Consumption Value Market Share by Application (2021-2032)
Figure 76. Middle East & Africa Blood Proteomics Services Consumption Value Market Share by Country (2021-2032)
Figure 77. Turkey Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 78. Saudi Arabia Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 79. UAE Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 80. Blood Proteomics Services Market Drivers
Figure 81. Blood Proteomics Services Market Restraints
Figure 82. Blood Proteomics Services Market Trends
Figure 83. Porters Five Forces Analysis
Figure 84. Blood Proteomics Services Industrial Chain
Figure 85. Methodology
Figure 86. Research Process and Data Source
Figure 1. Blood Proteomics Services Picture
Figure 2. Global Blood Proteomics Services Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Blood Proteomics Services Consumption Value Market Share by Type in 2025
Figure 4. Blood Proteomics
Figure 5. Blood Modification Proteomics
Figure 6. Olink (Targeted) Proteomics
Figure 7. Global Blood Proteomics Services Consumption Value by End User, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Blood Proteomics Services Consumption Value Market Share by End User in 2025
Figure 9. Universities and Research Institutes
Figure 10. Hospitals
Figure 11. Pharmaceutical Companies
Figure 12. Others
Figure 13. Global Blood Proteomics Services Consumption Value by Research Areas, (USD Million), 2021 & 2025 & 2032
Figure 14. Global Blood Proteomics Services Consumption Value Market Share by Research Areas in 2025
Figure 15. Oncology
Figure 16. Cardiovascular
Figure 17. Agriculture
Figure 18. Neuroscience
Figure 19. Other
Figure 20. Global Blood Proteomics Services Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 21. Blood Proteomics Services Consumption Value Market Share by Application in 2025
Figure 22. Disease Biomarker Research Picture
Figure 23. Drug Development Picture
Figure 24. Clinical Research Picture
Figure 25. Others Picture
Figure 26. Global Blood Proteomics Services Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 27. Global Blood Proteomics Services Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 28. Global Market Blood Proteomics Services Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 29. Global Blood Proteomics Services Consumption Value Market Share by Region (2021-2032)
Figure 30. Global Blood Proteomics Services Consumption Value Market Share by Region in 2025
Figure 31. North America Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 32. Europe Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 33. Asia-Pacific Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 34. South America Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 35. Middle East & Africa Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 36. Company Three Recent Developments and Future Plans
Figure 37. Global Blood Proteomics Services Revenue Share by Players in 2025
Figure 38. Blood Proteomics Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 39. Market Share of Blood Proteomics Services by Player Revenue in 2025
Figure 40. Top 3 Blood Proteomics Services Players Market Share in 2025
Figure 41. Top 6 Blood Proteomics Services Players Market Share in 2025
Figure 42. Global Blood Proteomics Services Consumption Value Share by Type (2021-2026)
Figure 43. Global Blood Proteomics Services Market Share Forecast by Type (2027-2032)
Figure 44. Global Blood Proteomics Services Consumption Value Share by Application (2021-2026)
Figure 45. Global Blood Proteomics Services Market Share Forecast by Application (2027-2032)
Figure 46. North America Blood Proteomics Services Consumption Value Market Share by Type (2021-2032)
Figure 47. North America Blood Proteomics Services Consumption Value Market Share by Application (2021-2032)
Figure 48. North America Blood Proteomics Services Consumption Value Market Share by Country (2021-2032)
Figure 49. United States Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 50. Canada Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 51. Mexico Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 52. Europe Blood Proteomics Services Consumption Value Market Share by Type (2021-2032)
Figure 53. Europe Blood Proteomics Services Consumption Value Market Share by Application (2021-2032)
Figure 54. Europe Blood Proteomics Services Consumption Value Market Share by Country (2021-2032)
Figure 55. Germany Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 56. France Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 57. United Kingdom Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 58. Russia Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 59. Italy Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 60. Asia-Pacific Blood Proteomics Services Consumption Value Market Share by Type (2021-2032)
Figure 61. Asia-Pacific Blood Proteomics Services Consumption Value Market Share by Application (2021-2032)
Figure 62. Asia-Pacific Blood Proteomics Services Consumption Value Market Share by Region (2021-2032)
Figure 63. China Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 64. Japan Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 65. South Korea Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 66. India Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 67. Southeast Asia Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 68. Australia Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 69. South America Blood Proteomics Services Consumption Value Market Share by Type (2021-2032)
Figure 70. South America Blood Proteomics Services Consumption Value Market Share by Application (2021-2032)
Figure 71. South America Blood Proteomics Services Consumption Value Market Share by Country (2021-2032)
Figure 72. Brazil Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 73. Argentina Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 74. Middle East & Africa Blood Proteomics Services Consumption Value Market Share by Type (2021-2032)
Figure 75. Middle East & Africa Blood Proteomics Services Consumption Value Market Share by Application (2021-2032)
Figure 76. Middle East & Africa Blood Proteomics Services Consumption Value Market Share by Country (2021-2032)
Figure 77. Turkey Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 78. Saudi Arabia Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 79. UAE Blood Proteomics Services Consumption Value (2021-2032) & (USD Million)
Figure 80. Blood Proteomics Services Market Drivers
Figure 81. Blood Proteomics Services Market Restraints
Figure 82. Blood Proteomics Services Market Trends
Figure 83. Porters Five Forces Analysis
Figure 84. Blood Proteomics Services Industrial Chain
Figure 85. Methodology
Figure 86. Research Process and Data Source
